Skip to content

Korea Equity Lens

  • About
  • IR Room
  • Research
    • Semiconductors
    • Bio & Healthcare
    • Defense
    • EV & Battery
    • Automotive
    • Energy
    • Robotics
    • Shipbuilding
  • Toggle search form
  • [Research] LigaChem Biosciences (141080) – Mirae Asset Securities | Clinical Milestones · Commercialization Potential · Platform PoC / 2025-05-23 Research
  • [Research] Alteogen (196170) – Shinhan Securities | Halozyme Patent Invalidated · Key Overhangs Materially Eased · Target Price Raised / 2026-05-14 Research
  • [Research] Samsung Electro-Mechanics (009150) – IBK Securities | MLCC Price Hike · Supply Shortage · Earnings Acceleration / 2026-07-31 Research
  • [Research] Samsung SDI (006400) – Mirae Asset Securities | Commencing Customer T ESS Business (Estimated) · SDC Asset Utilization · Valuation Gap Narrowing / 2026-02-03 Research
  • [Research] SK hynix (000660 / SKHY) – Mirae Asset | Multi-Year LTA · Price Downside Protection · ROE Sustainability / 2026-04-06 Research
  • [Research] Samsung SDI (006400) – Mirae Asset Securities | Data Center ESS · Potential SDC Monetization · Operating Profit Turnaround / 2026-06-26 Research
  • [Research] Samsung Electro-Mechanics (009150) – SK Securities | MLCC ASP Rise · FCBGA Margin Expansion · Earnings Upward Revision / 2026-07-31 Research
  • [Research] SK hynix (000660 / SKHY) – Mirae Asset | Memory Pricing · Operating Leverage · Shareholder Returns / 2026-01-30 Research

[Research] SK hynix (000660 / SKHY) – Hyundai Motor | LTA · Premium Product Mix · Blended ASP / 2026-07-14

Posted on July 14, 2026August 24, 2026 By ksb220805@gmail.com

Market: KOSPI (000660)

Brokerage : Hyundai Motor Securities

Analyst : Geunhyeong Noh (RA: Gayoung Yoon)

Investment Rating : BUY (Maintain)

Target Price : KRW 3,300,000 (Maintain)

Core Momentum : Long-term agreements are expected to provide greater earnings visibility under the AI-driven supply structure, while an expanding mix of premium products such as HBM4 and LPDDR6 supports higher blended ASP and profitability.

📊 1. [Valuation & Key Financial Metrics]

  • Stock Performance & Investment Rating
    • Investment Rating: BUY (Maintain)
    • Target Price: KRW 3,300,000 (Arithmetic average of valuations applying a 3x P/B on the average BPS of ’26 and ’27, and a 10x P/E on ’27 EPS)
    • Current Price (7/13): KRW 1,845,000
    • Upside Potential: 78.9%
  • Valuation Multiples
    • Annual P/E Trend: 2024 6.4x → 2025 11.0x → 2026(F) 6.7x → 2027(F) 4.9x → 2028(F) 4.2x
    • Annual P/B Trend: 2024 1.7x → 2025 3.9x → 2026(F) 4.0x → 2027(F) 2.2x → 2028(F) 1.4x
    • Stock Price Outlook: Downside rigidity below KRW 2M—representing a 2027 P/B level of 2x—is expected to be maintained given the surge in retained earnings projected over the next 3 years.
  • Key Financial Forecasts
    • 2024: Revenue KRW 66.19T, Operating Profit KRW 23.47T, Net Profit KRW 19.79T, EPS KRW 27,182, ROE 31.1%, Dividend Yield 1.3%
    • 2025: Revenue KRW 97.15T, Operating Profit KRW 47.21T, Net Profit KRW 42.92T, EPS KRW 58,955, ROE 44.2%, Dividend Yield 0.5%
    • 2026(F): Revenue KRW 365.14T, Operating Profit KRW 260.95T, Net Profit KRW 235.26T, EPS KRW 325,557 (Before KRW 325,070), ROE 90.9%, Dividend Yield 0.2%
    • 2027(F): Revenue KRW 571.06T, Operating Profit KRW 380.27T, Net Profit KRW 327.54T, EPS KRW 448,377 (Before KRW 418,390), ROE 58.5%, Dividend Yield 0.2%
    • 2028(F): Revenue KRW 779.99T, Operating Profit KRW 439.06T, Net Profit KRW 383.70T, EPS KRW 525,255, ROE 42.1%, Dividend Yield 0.2%

🚀 2. [Market Opportunities & Business Outlook]

  • Q2 Earnings Forecast & Temporary Factors
    • Q2 revenue and operating profit are projected to fall 3.1% and 1.6% below previous estimates, respectively, as DRAM Bit Growth is anticipated to miss prior expectations.
    • Despite incentive provisions being reflected since Q1, market consensus appears not to fully reflect this factor.
  • Supply Structure Differences: AI Cycle vs. Past Cloud Cycle
    • The current AI Cycle features fundamentally different supply characteristics compared to the 2017–2018 Cloud Cycle.
    • While memory suppliers contracted directly with CSPs during the Cloud Cycle, products like HBM and SOCAMM in the AI Cycle are supplied through entities such as NVIDIA, reducing the direct contracting proportion with CSPs compared to the past.
  • Long-Term Agreements (LTAs) and ASP Growth Drivers
    • Although the increase in CSP-facing ASP may fall short of market research estimates as more customers seek 5-year long-term contracts, the past pattern where slowed price growth led to product price declines within a year is not expected to repeat.
    • Current LTAs are contracted at higher levels than current market prices with reinforced fulfillment-related terms, ensuring high earnings visibility.
    • Focusing on Blended ASP enhancement through premium product mix expansion—including HBM4, HBM4e, LPDDR6, 3DS DIMM, and PCIe Gen7—remains valid.

📝 Editor’s Comment (Perspective & Thesis Verification)

The analyst evaluates SK hynix as an enterprise that has secured high earnings visibility, driven by structural changes involving major distribution channels like NVIDIA and long-term agreements (LTAs), setting it apart from past commodity-driven cycles. This perspective places greater emphasis on Blended ASP growth through premium product mix expansion (such as HBM4 and LPDDR6) and structural earnings generation capabilities rather than short-term fluctuations in price momentum or shipment volumes.

To verify whether this investment thesis unfolds as expected going forward, it is necessary to track whether the expansion of 5-year long-term agreements (LTAs) leads to tangible improvements in earnings visibility, and whether the rising proportion of premium products like HBM4 and LPDDR6 translates into higher Blended ASP and profitability. Such changes can be verified through future quarterly and annual earnings releases, official company IR materials, and regulatory filings.

📢 Disclaimer & Source

Source: This content has been structured and newly written based on officially disclosed financial facts and data from brokerage reports.

Investment Risk Notice: This content is provided for informational and linguistic reference purposes only. Under no circumstances does it constitute financial advice or a recommendation to buy or sell any specific securities. All investment decisions and financial responsibilities rest entirely with the investor.

Contact: Compliance and Copyright Inquiries (ksb220805@gmail.com)

Search by
Company Name or Stock Ticker.
Research, Semiconductors

Post navigation

Previous Post: [Research] SK hynix (000660 / SKHY) – Mirae Asset | Big Tech Backlogs · Memory Supply Tightness · Earnings Growth / 2026-07-14
Next Post: [Research] Hanwha Ocean (042660) – Kiwoom | Merchant Earnings Growth · 2H Order Momentum · US Naval Defense / 2026-07-15

Related Posts

  • [Research] Alteogen (196170) – Shinhan Securities | GSK Deal Supports Low Patent Risk View · Keytruda SC Royalty Calibrated · Target Price Adjusted / 2026-01-21 Research
  • [Research] Samsung Electro-Mechanics (009150) – IBK Securities | MLCC Price Hike · Supply Shortage · Earnings Acceleration / 2026-07-31 Research
  • [Research] Celltrion (068270) – Daishin Securities | Merger Noise Resolution · Portfolio Expansion Leverage · CMO Revenue Visibility / 2026-05-19 Research
  • [Research] Samsung Biologics (207940) – iM Securities | New Plant Operations · PolyPeptide Acquisition · Portfolio Diversification / 2026-07-24 Research
  • [Research] SK hynix (000660 / SKHY) – Hanwha | LTA · HBM · Earnings Sustainability / 2026-04-24 Research
  • [Research] Samsung SDI (006400) – Daishin Securities | Earlier Turnaround · North America ESS Expansion · LFP Order Pipeline / 2026-07-31 Research
  • [Research] Hanwha Ocean (042660) – Yuanta | Merchant Vessel Margin · FX Gains · Earnings Differentiation / 2026-07-28 Research
  • [Research] SK hynix (000660 / SKHY) – Daishin | Legacy Memory Pricing · LTA · ADR / 2026-02-23 Research
  • [Research] Samsung SDI (006400) – Mirae Asset Securities | Commencing Customer T ESS Business (Estimated) · SDC Asset Utilization · Valuation Gap Narrowing / 2026-02-03 Research
  • [Research] SK hynix (000660 / SKHY) – DS Investment | Server Memory Demand · HBM3E Pricing · Margin Expansion / 2026-01-30 Research
  • [Research] SK hynix (000660 / SKHY) – DS Investment | Memory ASP · High-Value Product Mix · Supply Tightness / 2026-04-23 Research
  • [Research] Samsung Electro-Mechanics (009150) – Shinhan Securities | High-Value Order Expansion · ASP Growth · Earnings Upward Revision / 2026-07-31 Research
  • [Research] Samsung SDI (006400) – iM Securities | AIDC ESS Demand · US Regulation Benefits · Profit Turnaround / 2026-06-30 Research
  • [Research] Samsung Biologics (207940) – iM Securities | Annual Operating Profit Surpasses KRW 2T · Pure-CDMO Transition · Three-Pillar Growth Strategy / 2026-01-22 Research

Copyright © 2026 Korea Equity Lens.

Powered by PressBook News Dark theme